Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Racle

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Elife|October 9, 2024
Robust estimation of cancer and immune cell-type proportions from bulk tumor ATAC-Seq dataAurélie Anne-Gaëlle Gabriel, Julien Racle, Maryline Falquet, et al.
Elife|November 14, 2017
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression dataJulien Racle, Kaat de Jonge, Petra Baumgaertner, et al.
Iscience|May 2, 2022
Deciphering the landscape of phosphorylated HLA-II ligandsMarthe Solleder, Julien Racle, Philippe Guillaume, et al.
Plos One|December 7, 2013
A novel pulse-chase SILAC strategy measures changes in protein decay and synthesis rates induced by perturbation of proteostasis with an Hsp90 inhibitorIvo Fierro-Monti, Julien Racle, Celine Hernandez, et al.
Plos One|December 7, 2013
Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapyIvo Fierro-Monti, Pablo Echeverria, Julien Racle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2018
The Length Distribution and Multiple Specificity of Naturally Presented HLA-I LigandsDavid Gfeller, Philippe Guillaume, Justine Michaux, et al.
Molecular & Cellular Proteomics : MCP|December 19, 2019
Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I LigandsMarthe Solleder, Philippe Guillaume, Julien Racle, et al.
Cell Systems|January 5, 2023
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8<sup>+</sup> T-cell epitopesDavid Gfeller, Julien Schmidt, Giancarlo Croce, et al.
Molecular & Cellular Proteomics : MCP|December 16, 2017
High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) LigandomeChloe Chong, Fabio Marino, HuiSong Pak, et al.
Oncoimmunology|March 1, 2021
Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patientsKaat de Jonge, Laure Tillé, Joao Lourenco, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Elife|October 9, 2024
Robust estimation of cancer and immune cell-type proportions from bulk tumor ATAC-Seq dataAurélie Anne-Gaëlle Gabriel, Julien Racle, Maryline Falquet, et al.
Elife|November 14, 2017
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression dataJulien Racle, Kaat de Jonge, Petra Baumgaertner, et al.
Iscience|May 2, 2022
Deciphering the landscape of phosphorylated HLA-II ligandsMarthe Solleder, Julien Racle, Philippe Guillaume, et al.
Plos One|December 7, 2013
A novel pulse-chase SILAC strategy measures changes in protein decay and synthesis rates induced by perturbation of proteostasis with an Hsp90 inhibitorIvo Fierro-Monti, Julien Racle, Celine Hernandez, et al.
Plos One|December 7, 2013
Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapyIvo Fierro-Monti, Pablo Echeverria, Julien Racle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2018
The Length Distribution and Multiple Specificity of Naturally Presented HLA-I LigandsDavid Gfeller, Philippe Guillaume, Justine Michaux, et al.
Molecular & Cellular Proteomics : MCP|December 19, 2019
Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I LigandsMarthe Solleder, Philippe Guillaume, Julien Racle, et al.
Cell Systems|January 5, 2023
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8<sup>+</sup> T-cell epitopesDavid Gfeller, Julien Schmidt, Giancarlo Croce, et al.
Molecular & Cellular Proteomics : MCP|December 16, 2017
High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) LigandomeChloe Chong, Fabio Marino, HuiSong Pak, et al.
Oncoimmunology|March 1, 2021
Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patientsKaat de Jonge, Laure Tillé, Joao Lourenco, et al.
Pageof 4